PALI Q1 2026 Earnings EPS Misses Estimates as Palisade Bio Advances Pipeline Efforts PDS Biotechnology Q1 2026 Earnings Narrowed Loss Per Share and Clinical Progress Drive Positive Market Response Indaptus Therapeutics Inc INDP Q4 2025 Earnings Deeper Loss Yet Shares Surge on Pipeline Progress FBNC Q1 2026 Earnings Slight EPS Beat Amid Stable Performance Ridgepost Capital Inc RPC Q1 2026 Earnings Slight EPS Beat Amid Mixed Signals Stock Slips Moderna Inc MRNA Q1 2026 Earnings Narrowerthanexpected loss as cost controls offset revenue headwinds